Full Name
Dr. Pierre Laneuville
McGill University Health Center (MUHC)
Speaker Bio
Dr. Pierre Laneuville is an Associate Professor (GFT-U) in the Department of Medicine and Oncology at McGill University, the former Head of Hematology for the McGill University Health Center (MUHC).
Dr. Laneuville obtained an Honours B.Sc. in Biochemistry at McMaster University, his medical degree at the University of Ottawa, trained in internal Medicine at McGill University, and completed his hematology sub-specialty and research training with Dr. B.A. Cooper at the Royal Victoria Hospital and McGill University from 1985 to 1989. He then joined the staff and faculty at the Royal Victoria Hospital and McGill University and has focused his clinical and laboratory research activities on hematological malignancies. Dr. Laneuville is best known for his research on the molecular mechanisms underlying the genesis and transformation of chronic myelogenous leukemia.
He is a past President of the Canadian Hematological Society and Chairman of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia (CCGM-CML). He has served on numerous basic and clinical research panels including the Medical Research Council of Canada, the Leukemia Research Fund of Canada, and the National Cancer Institute of Canada Clinical Trials Hematology Executive.
He has held a number of research grants supported by the MRC, LRFC, CRSI, MSSC, and is actively engaged in clinical trials for hematological malignancies and stem cell transplantation. He is currently the Medical Director of the McGill University Health Centre Research Institute Cellular Therapy Laboratory.
Dr. Pierre Laneuville